Table 5.
Variable | High-dose group | Low-dose group |
---|---|---|
In-hospital mortality | 10/22 (45%) | 2/32 (6.3%) |
Retransplantation | 3/12 (25%) | 7/30 (23%) |
Out-of-hospital mortality | 0/12 (0%) | 9/30 (30%) |
Graft survival at 6 months | 41% | 44% |
Mean follow-up | 5.8 years (2.2–9.6 years) | 4.4 years (1.4–8.6 years) |
Development of new/progression of TCAD | 1 patient—continued graft survival | 8 patients—all died before 6 months |